Company: BKYI
Filing Date: 2025-04-23
Form Type: 10-K
Source: 0001437749-25-012824
Chunk: 593

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-04-23
Form: 10-K
Item: Item 9C
Chunk 593
---
 (1,711,200)  (2,349,023)  (2,600,000)  (3,800,000)  (4,311,200)  (6,149,023)
 Comprehensive loss   (1,619,170)  (2,221,629)  (2,600,000)  (3,800,000)  (4,219,170)  (6,021,629)
 Basic and Diluted Loss per Common Share   (3.07)  (4.12)  (4.67)  (6.67)  (7.74)  (10.79)

       66

   NOTE T—SUBSEQUENT EVENTS
    
   On  January 8, 2025, the Company issued 14,970 shares of common stock in repayment of $25,000 of the principal due on the 2024 Note.
    
   On  January 10, 2025, 679 shares of restricted common stock were forfeited by employees who left the Company before the lapse of the restriction period applicable to such shares.
    
   On  January 10, 2025, 5,000 shares of restricted common stock were forfeited by employees who left the Company before the lapse of the restriction period applicable to such shares.
    
       On  January 15, 2025, the Company entered into a warrant exercise agreement under which the counterparty agreed to exercise outstanding warrants to purchase 2,061,112 shares of common stock at an exercise price of $1.85 per share resulting in gross proceeds of approximately $3.8 million, prior to deducting placement agent fees and estimated offering expenses. In connection with this transaction, the Company issued additional warrants to purchase an aggregate 3,091,668 shares of common stock at an exercise price of $2.15 per share. 
    
   On  January 15, 2025, the Company issued 149,635 shares of common stock in repayment of $205,000 of the principal due on the 2024 Note.
    
   On  January 15, 2025, the Company issued 340,000 shares of common stock in repayment of $629,000 of the principal due on the 2024 Note.
    
   On  January 17,